胰腺癌中的长非编码RNA:从生物标志物到治疗点
Esra Güzel Tanoğlu1,2, Seyfure Adigüzel1,2, Alpaslan Tanoğlu3
1Department of Molecular Biology and Genetics, Hamidiye Institute of Health Sciences, University of Health Sciences, İstanbul, Turkiye.
Turkish journal of medical sciences
|May 30, 2024
概括
长非编码RNAs (lncRNAs) 在胰腺癌 (PC) 的发展中起着关键作用. 本综述探讨了lncRNAs的瘤行为和作为PC的诊断和治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 是超过200个核酸长的RNA分子,由RNA聚合酶II转录,与信使RNA (mRNA) 共享特性.
- 非编码RNA (ncRNA) 研究领域早于微RNA的发现, lncRNA基因比蛋白质编码基因更多.
- lncRNAs在癌症相关过程中至关重要,包括细胞增殖,分化和迁移,使它们成为当前分子研究的焦点.
研究的目的:
- 审查关于胰腺癌 (PC) 中长非编码RNA (lncRNA) 的关键信息.
- 讨论 lncRNAs 的生物和瘤行为,特别是在 PC 的背景下.
- 探索 lncRNAs 作为诊断瘤标记物和PC治疗策略中的潜在应用.
主要方法:
- 关于lncRNAs和胰腺癌的当前研究的文献综述.
- 对 lncRNAs 在癌症生物学中的分子功能和作用的分析.
- 综合关于PC中 lncRNAs 的诊断和治疗潜力的信息.
主要成果:
- lncRNAs表现出与胰腺癌进展相关的多种生物和瘤行为.
- lncRNAs涉及到关键的癌症过程,如PC中的增殖,分化和迁移.
- 新出现的证据表明,lncRNAs作为PC的生物标志物和治疗点具有显著的前景.
结论:
- lncRNAs是胰腺癌分子格局的组成部分.
- 了解PC中的lncRNA功能可以导致新的诊断和治疗方法.
- 对lncRNAs的进一步研究为对抗胰腺癌提供了一个有希望的途径.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
265
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
